Search

everythinglearnresearchcommunity

for

Search:↓

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

Testosterone therapy improves physical function, strength, and body composition in older men with low testosterone levels.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

Modern hair transplants use small grafts for a natural look and drugs to prevent further loss, with high patient satisfaction.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Finasteride may cause lasting sexual, mental, and physical symptoms; use with caution.

Some nonsurgical hair loss treatments are effective, especially if started early.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Saw palmetto helps with nighttime urination and urine flow, similar to finasteride.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Using mirabegron and solifenacin together is safe and more effective for treating overactive bladder than using either drug alone.

White hirsute women with PCOS have higher insulin resistance, but similar nitric oxide and fibrinogen levels compared to those with idiopathic hirsutism.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Finasteride safely treats hair loss without harming hormones or reproduction, but may slightly reduce sexual function.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

Herbal remedies can cause adverse effects and need more safety research.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

Mutations in the SRD5A3 gene cause a new type of glycosylation disorder by blocking the production of a molecule necessary for protein glycosylation.

Hair loss in men is common, treatable, but not curable.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Different types of stem cells with unique roles exist in blood, skin, and intestines, and this variety is important for tissue repair.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.